• Cat-intel
  • MedIntelliX
  • Resources
  • About Us
  • Request Free Sample ×

    Kindly complete the form below to receive a free sample of this Report

    Leading companies partner with us for data-driven Insights

    clients tt-cursor

    Contraceptive Device Market

    ID: MRFR/HC/40329-HCR
    200 Pages
    Garvit Vyas
    September 2025

    Contraceptive Device Market Research Report By Type (Intrauterine Devices, Condoms, Implants, Pills, Emergency Contraceptive Pills), By Material (Plastic, Rubber, Metal, Surgical Grade Silicone), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Clinics), By End Use (Household, Healthcare Providers, Educational Institutions) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2035

    Share:
    Download PDF ×

    We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

    Contraceptive Device Market Size, Growth Outlook 2035 Infographic
    Purchase Options
    $ 4,950.0
    $ 5,950.0
    $ 7,250.0

    Contraceptive Device Market Summary

    The global contraceptive device market is projected to grow from 30.6 USD billion in 2024 to 42.5 USD billion by 2035.

    Key Market Trends & Highlights

    Contraceptive Device Key Trends and Highlights

    • The market is expected to experience a compound annual growth rate of 3.04 percent from 2025 to 2035.
    • By 2035, the market valuation is anticipated to reach 42.5 USD billion, indicating robust growth.
    • In 2024, the market is valued at 30.6 USD billion, reflecting a strong foundation for future expansion.
    • Growing adoption of contraceptive devices due to increasing awareness of family planning is a major market driver.

    Market Size & Forecast

    2024 Market Size 30.6 (USD Billion)
    2035 Market Size 42.5 (USD Billion)
    CAGR (2025-2035) 3.04%

    Major Players

    Watson Pharmaceuticals, Merck, Novartis, Durex, Teva Pharmaceuticals, CooperSurgical, Hologic, Pfizer, Getraube, Contraline, AbbVie, Mylan, Acuity Medical, Bayer, Johnson and Johnson

    Contraceptive Device Market Trends

    The Contraceptive Device Market is experiencing significant growth driven by various key market drivers. Growing awareness of family planning and reproductive health is increasing the adoption of contraceptive devices. Additionally, the rise in sexually transmitted diseases is pushing individuals and couples toward safer options. The increasing acceptance of contraceptives in many regions is also propelling the market forward. Healthcare providers are promoting contraceptive use as a vital component of women's health, contributing to the market's expansion.

    Opportunities in the market are abundant, especially with the introduction of innovative products and technology. Companies can explore advanced technologies that improve device efficacy and comfort, catering to the needs of a more diverse population. Emerging markets present significant potential, as changes in societal norms and improvements in healthcare access are encouraging more people to use contraceptive devices.

    Customization of products to meet specific needs also opens new avenues for growth and development. Recent trends indicate a shift towards personalized contraceptive solutions and an emphasis on sustainable products. As consumers become more environmentally conscious, the demand for eco-friendly contraceptive options is rising. Increased investment in research and development is leading to the creation of more effective and user-friendly devices, further enhancing the market landscape. Digital health technologies are also integrating with contraceptive solutions, offering user-friendly apps and platforms that foster better understanding and adherence to contraceptive methods.

    These elements are reshaping the market, making it crucial for stakeholders to adapt and innovate in line with evolving consumer preferences and societal changes.

    The Global Contraceptive Device Market is poised for growth as increasing awareness of reproductive health and family planning drives demand for innovative contraceptive solutions.

    U.S. Department of Health and Human Services

    Contraceptive Device Market Drivers

    Diverse Product Offerings

    The Global Contraceptive Device Market Industry benefits from a diverse range of product offerings that cater to varying consumer preferences and needs. This diversity includes hormonal contraceptives, barrier methods, and permanent solutions, allowing consumers to choose options that align with their lifestyles. For instance, the availability of non-hormonal IUDs appeals to those seeking alternatives to hormonal methods. Additionally, the introduction of eco-friendly contraceptive options is gaining traction among environmentally conscious consumers. This variety not only enhances consumer choice but also drives market growth as manufacturers innovate to meet the evolving demands of the population.

    Market Growth Projections

    The Global Contraceptive Device Market Industry is poised for substantial growth, with projections indicating a market value of 30.6 USD Billion in 2024 and an anticipated increase to 42.5 USD Billion by 2035. This growth trajectory suggests a robust compound annual growth rate (CAGR) of 3.04% from 2025 to 2035. Such projections reflect the increasing recognition of the importance of contraceptive devices in reproductive health and family planning. As more individuals seek effective solutions to manage their reproductive health, the market is likely to expand, driven by innovations, government initiatives, and evolving consumer preferences.

    Government Initiatives and Policies

    Government initiatives and policies significantly influence the Global Contraceptive Device Market Industry. Many countries are implementing policies that promote access to contraceptive devices as part of broader public health strategies. For instance, subsidized contraceptive programs in various nations aim to reduce costs for consumers, thereby increasing accessibility. Additionally, policies that support reproductive health education in schools contribute to informed decision-making among young individuals. Such initiatives are likely to foster a more favorable environment for contraceptive use, ultimately driving market growth and ensuring that the industry adapts to the evolving needs of the population.

    Rising Demand for Family Planning Services

    The Global Contraceptive Device Market Industry is witnessing a surge in demand for family planning services, driven by changing societal norms and economic factors. As more individuals prioritize career development and personal goals, the need for effective contraceptive solutions becomes increasingly apparent. This trend is particularly evident in urban areas, where access to family planning services is more readily available. The growing acceptance of family planning as a means to achieve economic stability and improved quality of life is likely to propel market growth. The industry is expected to expand at a CAGR of 3.04% from 2025 to 2035, reflecting this rising demand.

    Increasing Awareness of Reproductive Health

    The Global Contraceptive Device Market Industry experiences growth due to heightened awareness regarding reproductive health. Educational campaigns led by governments and NGOs emphasize the importance of family planning and contraceptive use. This awareness is crucial in regions with high birth rates, where access to contraceptive devices can significantly reduce unintended pregnancies. For instance, in many developing countries, initiatives have been launched to educate women about their reproductive rights and available contraceptive options. As a result, the market is projected to reach 30.6 USD Billion in 2024, reflecting a growing recognition of the need for effective contraceptive solutions.

    Technological Advancements in Contraceptive Devices

    Technological innovations play a pivotal role in shaping the Global Contraceptive Device Market Industry. The introduction of advanced contraceptive methods, such as long-acting reversible contraceptives (LARCs) and digital health solutions, enhances user experience and effectiveness. For example, the development of intrauterine devices (IUDs) with improved materials and designs has increased their acceptance among users. Furthermore, the integration of mobile applications for tracking menstrual cycles and contraceptive use is gaining traction. These advancements not only improve user satisfaction but also contribute to the projected market growth, with an anticipated value of 42.5 USD Billion by 2035.

    Market Segment Insights

    Contraceptive Device Market Type Insights  

    The Contraceptive Device Market showcases a diverse range of products categorized under different types, each contributing to its overall growth and dynamics. In 2024, the market is expected to achieve a value of 30.56 USD Billion, showcasing the increasing demand for effective contraceptive methods. The market segmentation includes Intrauterine Devices, Condoms, Implants, Pills, and Emergency Contraceptive Pills, each demonstrating unique characteristics and demand trends within the industry.

    Among these, Condoms hold a significant position, valued at 10.0 USD Billion in 2024, and are expected to rise to 14.0 USD Billion by 2035. This sub-segment attracts considerable attention due to its dual benefits of preventing both unintended pregnancies and sexually transmitted infections, making it a popular choice among consumers. Following closely, Intrauterine Devices are projected to provide substantial revenue, starting at 8.0 USD Billion in 2024 and increasing to 11.0 USD Billion by 2035. Their long-term effectiveness and ease of use contribute to their growing acceptance, making them a viable option for many women worldwide.

    Moreover, the Implants segment, valued at 6.0 USD Billion in 2024 and expected to grow to 8.5 USD Billion by 2035, also exemplifies the shift towards long-acting methods of contraception. This reflects a changing consumer preference towards products that require minimal user intervention. On the other hand, Pills are projected to generate 5.5 USD Billion in 2024, increasing to 7.0 USD Billion by 2035, indicating a steady demand despite the influx of newer contraceptive technologies.

    Emergency Contraceptive Pills, valued at 1.06 USD Billion in 2024 and expected to reach 2.0 USD Billion by 2035, while relatively smaller in comparison, play a crucial role in providing a safety net for women facing unexpected situations regarding family planning.

    The overall Contraceptive Device Market revenue is influenced by several growth drivers, including increasing awareness of reproductive health, sexual education, and the rising prevalence of unintended pregnancies. The market also faces challenges such as varying cultural acceptance and restrictions associated with contraceptive usage in different regions. Nevertheless, there are numerous opportunities for growth, particularly in expanding access to contraceptive options in developing countries, which could significantly impact the overall market landscape.

    Contraceptive Device Market Material Insights  

    The Contraceptive Device Market, focusing on the Material segment, plays a vital role in shaping product performance and user acceptance. By 2024, this market is expected to be valued at 30.56 billion USD, with various materials used in manufacturing contraceptive devices contributing significantly to functionality and reliability. Materials such as plastic and rubber often dominate this market, providing flexibility and comfort for users. The use of surgical-grade silicone is increasingly sought after for its biocompatibility and safety profile, especially in intrauterine devices and implants.

    Metal components also have importance, particularly in devices that require durability and strength. Each of these materials has unique properties that cater to different consumer needs, driving innovation and development in the Contraceptive Device Market industry. As these materials continue to evolve, the Contraceptive Device Market data shows a trend toward sustainable and safer materials, highlighting opportunities for growth amidst ongoing challenges related to regulatory standards and consumer health concerns. As a result, understanding the nuances of the Contraceptive Device Market segmentation by material is crucial for stakeholders aiming to leverage market trends effectively.

    Contraceptive Device Market Distribution Channel Insights  

    The Distribution Channel segment of the Contraceptive Device Market plays a crucial role in ensuring product accessibility and availability to consumers. By 2024, this segment is expected to be part of a market valued at 30.56 billion USD, reflecting the growing demand for contraceptive devices. Each distribution channel offers unique advantages; for instance, Hospital Pharmacies are vital as they provide immediate access to contraceptive options during medical consultations, while Retail Pharmacies offer convenience and discretion to consumers. Online Pharmacies are emerging as significant players, appealing particularly to younger demographics who prefer privacy and ease of purchasing.

    Clinics also serve as essential points for distribution, providing professional guidance and a trusted environment for accessing contraceptive devices. As the Contraceptive Device Market statistics reveal, the diversity in distribution channels facilitates broader reach and availability, catering to varying consumer preferences. This segment's growth is supported by increasing awareness regarding contraceptive options and the rise in reproductive health initiatives worldwide, driving market growth. However, challenges such as regulatory hurdles and the need for quality assurance remain significant considerations in this evolving landscape.

    Contraceptive Device Market End Use Insights  

    The Contraceptive Device Market revenue reflects significant growth trends, particularly when observing the End Use segment. By 2024, the market is expected to be valued at approximately 30.56 USD Billion, demonstrating the ongoing demand for contraceptive solutions. The segmentation of this market into different End Use categories: Households, Healthcare Providers, and Educational Institutions highlight diverse usage patterns and preferences. Healthcare Providers play a crucial role, offering professional advice and access to contraceptive methods, thereby dominating overall market activities due to their direct interface with consumers.

    Meanwhile, Households signify a substantial portion as personal choices in contraception reflect cultural and socioeconomic factors. Educational Institutions contribute significantly to awareness and understanding of contraceptive options, making them vital in shaping future generations’ views on family planning. The growth of these segments is driven by increasing awareness of reproductive health, evolving cultural norms, and policies promoting family planning. However, challenges such as regulatory frameworks and accessibility to healthcare OEM facilities can impact growth dynamics. Understanding these segments is essential for grasping Contraceptive Device Market statistics and leveraging growth opportunities effectively.

    Get more detailed insights about Contraceptive Device Market Size, Growth Outlook 2035

    Regional Insights

    The Contraceptive Device Market is progressively evolving, showcasing substantial regional segmentation characterized by varied market valuations. In 2024, North America leads the pack with a valuation of 10.5 USD Billion, anticipated to rise to 15.0 USD Billion by 2035, demonstrating a majority holding that signifies strong market growth driven by extensive healthcare infrastructure and awareness. Following closely, Europe reflects a valuation of 8.0 USD Billion in 2024, with projections indicating an increase to 11.5 USD Billion by 2035, underlining the region's commitment to reproductive health.

    The APAC region, valued at 7.5 USD Billion in 2024 and expected to reach 10.0 USD Billion by 2035, highlights significant potential due to the growing population and increasing access to contraceptive options. South America, while smaller in scale with a valuation of 2.5 USD Billion in 2024 and 3.5 USD Billion in 2035, still demonstrates growing recognition of family planning. Meanwhile, the MEA region, valued at 2.06 USD Billion in 2024 and projected to grow to 2.5 USD Billion by 2035, showcases emerging opportunities amid persistent challenges like accessibility and cultural barriers.

    This diverse market landscape reflects varying socio-economic conditions, healthcare policies, and cultural attitudes toward contraceptive use, contributing to the overall dynamics of the Contraceptive Device Market revenue and industry trajectory.

    Contraceptive Device Market Regional Insights  

    Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

    Key Players and Competitive Insights

    The Contraceptive Device Market is characterized by a competitive landscape that is influenced by various factors, including technological advancements, regulatory frameworks, and changing consumer preferences. The market comprises a wide range of contraceptive devices, such as intrauterine devices, condoms, hormonal implants, and vaginal rings, each catering to diverse demographics and cultural needs. Key manufacturers continually innovate in terms of product design, materials, and efficacy to capture a larger share of the market while adhering to safety and regulatory guidelines. The competitive environment is also marked by strategic collaborations, partnerships, and acquisitions aimed at expanding product portfolios and market reach.

    Understanding these dynamics is crucial for stakeholders as they navigate through a market driven by both challenges and opportunities.

    Watson Pharmaceuticals possesses a strong presence in the Contraceptive Device Market, bolstered by an extensive portfolio of reproductive health products that resonate well with consumers. The company focuses on developing innovative contraceptives that are not only effective but also align with the evolving preferences and values of women across different regions. Watson Pharmaceuticals has made significant investments in research and development, enhancing its capability to introduce cutting-edge technologies that cater to specific contraceptive needs.

    Furthermore, the company leverages its established distribution networks to ensure that its products are widely accessible. This market strength is augmented by positive brand recognition and a commitment to consumer education regarding contraceptive options, fostering trust and reliability among its clientele. Merck also plays a pivotal role in the Contraceptive Device Market, known for its diverse and high-quality product offerings that address various contraceptive needs. The company emphasizes science-driven innovation to develop contraceptive solutions, ensuring they are safe, effective, and user-friendly.

    Merck’s commitment to research allows it to stay ahead in a rapidly evolving market by addressing different segments of the population, including both long-acting reversible contraceptives and short-term solutions. With a robust distribution network, Merck enhances its market presence, making its contraceptive devices accessible to consumers in multiple regions. Additionally, Merck is reputed for its proactive approach to advocating for women's health and reproductive rights, which resonates positively with consumers, further solidifying its competitive edge in the market.

    Key Companies in the Contraceptive Device Market market include

    Industry Developments

    • Q2 2024: Bayer receives FDA approval for new hormonal IUD, Mirena Plus Bayer announced that the U.S. Food and Drug Administration approved its new hormonal intrauterine device (IUD), Mirena Plus, for up to 8 years of use, expanding contraceptive options for women in the United States.
    • Q2 2024: CooperSurgical launches next-generation copper IUD, Paragard Ultra, in Europe CooperSurgical announced the commercial launch of Paragard Ultra, a next-generation copper intrauterine device, in select European markets following CE Mark approval.
    • Q3 2024: Organon acquires Belgian contraceptive implant startup FemTech Solutions for $120 million Organon completed the acquisition of FemTech Solutions, a Belgian startup specializing in biodegradable contraceptive implants, to expand its women's health portfolio.
    • Q1 2024: Veru Inc. announces FDA clearance for OTC female condom, FC3 Veru Inc. received U.S. FDA clearance for its FC3 female condom, allowing over-the-counter sales in the United States and expanding access to non-prescription barrier contraception.
    • Q2 2025: Teva Pharmaceuticals partners with PATH to develop low-cost contraceptive implants for emerging markets Teva Pharmaceuticals entered a strategic partnership with global health nonprofit PATH to co-develop and distribute affordable contraceptive implants in low- and middle-income countries.
    • Q1 2025: Agile Therapeutics secures $30 million in Series C funding to advance transdermal contraceptive patch pipeline Agile Therapeutics raised $30 million in a Series C funding round to accelerate development and commercialization of its next-generation transdermal contraceptive patches.
    • Q3 2024: FDA approves Evofem Biosciences’ new vaginal pH modulator contraceptive gel Evofem Biosciences received FDA approval for its new non-hormonal contraceptive gel, expanding non-invasive birth control options for women in the U.S.
    • Q2 2024: Pregna International opens new manufacturing facility for IUDs in India Pregna International inaugurated a new state-of-the-art manufacturing facility in Pune, India, to increase production capacity for intrauterine devices and meet rising global demand.
    • Q1 2025: Boston Scientific announces acquisition of contraceptive device maker OCON Healthcare Boston Scientific disclosed in an SEC filing its acquisition of OCON Healthcare, an Israeli company specializing in innovative intrauterine contraceptive devices, to strengthen its women's health division.
    • Q2 2025: Mylan launches generic version of NuvaRing in the U.S. Mylan announced the U.S. launch of its FDA-approved generic version of the NuvaRing vaginal contraceptive, increasing access to affordable hormonal contraception.
    • Q3 2024: Sebela Pharmaceuticals receives FDA approval for new long-acting copper IUD, VeraT IUD Sebela Pharmaceuticals announced FDA approval for VeraT IUD, a new long-acting copper intrauterine device, offering an additional non-hormonal birth control option.
    • Q1 2024: Daré Bioscience announces positive Phase 3 results for investigational monthly contraceptive ring Daré Bioscience reported positive topline results from its Phase 3 clinical trial of DARE-RING-001, a monthly contraceptive vaginal ring, paving the way for regulatory submission.

    Future Outlook

    Contraceptive Device Market Future Outlook

    The Global Contraceptive Device Market is projected to grow at a 3.04% CAGR from 2024 to 2035, driven by increasing awareness, technological advancements, and expanding healthcare access.

    New opportunities lie in:

    • Develop eco-friendly contraceptive devices to meet sustainability demands.
    • Leverage telehealth platforms for remote consultations and device prescriptions.
    • Invest in educational campaigns targeting underserved populations to enhance market penetration.

    By 2035, the market is expected to exhibit robust growth, reflecting evolving consumer needs and innovative solutions.

    Market Segmentation

    Contraceptive Device Market Type Outlook

    • Intrauterine Devices
    • Condoms
    • Implants
    • Pills
    • Emergency Contraceptive Pills

    Contraceptive Device Market End Use Outlook

    • Household
    • Healthcare Providers
    • Educational Institutions

    Contraceptive Device Market Material Outlook

    • Plastic
    • Rubber
    • Metal
    • Surgical Grade Silicone

    Contraceptive Device Market Regional Outlook

    • North America
    • Europe
    • South America
    • Asia Pacific
    • Middle East and Africa

    Contraceptive Device Market Distribution Channel Outlook

    • Hospital Pharmacies
    • Retail Pharmacies
    • Online Pharmacies
    • Clinics

    Report Scope

     

    Attribute/Metric Source: Details
    MARKET SIZE 2023 29.66 (USD Billion)
    MARKET SIZE 2024 30.56 (USD Billion)
    MARKET SIZE 2035 42.5 (USD Billion)
    COMPOUND ANNUAL GROWTH RATE (CAGR) 3.05% (2025 - 2035)
    REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
    BASE YEAR 2024
    MARKET FORECAST PERIOD 2025 - 2035
    HISTORICAL DATA 2019 - 2024
    MARKET FORECAST UNITS USD Billion
    KEY COMPANIES PROFILED Watson Pharmaceuticals, Merck, Novartis, Durex, Teva Pharmaceuticals, CooperSurgical, Hologic, Pfizer, Getraube, Contraline, AbbVie, Mylan, Acuity Medical, Bayer, Johnson and Johnson
    SEGMENTS COVERED Type, Material, Distribution Channel, End Use, Regional
    KEY MARKET OPPORTUNITIES Rising awareness of family planning, Increasing demand for long-term solutions, Expansion in emerging markets, Growth in e-commerce contraceptive sales, Technological advancements in devices
    KEY MARKET DYNAMICS Rising awareness of family planning, Increasing regulatory approvals, Technological advancements in devices, Growing demand for non-invasive options, Expanding access in emerging markets
    COUNTRIES COVERED North America, Europe, APAC, South America, MEA

    FAQs

    What is the expected market size of the Global Contraceptive Device Market in 2024?

    The Global Contraceptive Device Market is expected to be valued at 30.56 USD billion in 2024.

    What is the projected market size for the Global Contraceptive Device Market by 2035?

    By 2035, the Global Contraceptive Device Market is projected to reach a value of 42.5 USD billion.

    What is the expected compound annual growth rate (CAGR) for the Global Contraceptive Device Market from 2025 to 2035?

    The expected CAGR for the Global Contraceptive Device Market from 2025 to 2035 is 3.05%.

    Which region is expected to dominate the Global Contraceptive Device Market in 2024?

    North America is expected to dominate the Global Contraceptive Device Market with a value of 10.5 USD billion in 2024.

    What is the market size for condoms within the Global Contraceptive Device Market in 2024?

    The market size for condoms is valued at 10.0 USD billion within the Global Contraceptive Device Market in 2024.

    Who are the key players in the Global Contraceptive Device Market?

    Major players in the Global Contraceptive Device Market include Watson Pharmaceuticals, Merck, Novartis, and Durex among others.

    What will be the market value of Intrauterine Devices in 2035?

    The market value of Intrauterine Devices is expected to reach 11.0 USD billion by 2035.

    How much is the South American market for contraceptive devices expected to grow by 2035?

    The South American market for contraceptive devices is expected to grow to 3.5 USD billion by 2035.

    What is the expected value of emergency contraceptive pills in the market by 2035?

    The expected value of emergency contraceptive pills in the Global Contraceptive Device Market is 2.0 USD billion by 2035.

    What key trends are influencing the growth of the Global Contraceptive Device Market?

    Key trends influencing the growth of the Global Contraceptive Device Market include increased access to family planning and advancements in contraceptive technologies.

    Report Infographic
    Free Sample Request

    Kindly complete the form below to receive a free sample of this Report

    Customer Strories

    “I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

    Victoria Milne Founder
    Case Study

    Chemicals and Materials